Archive

All generic drugs are not equal, study finds

Written by | 1 Mar 2025

Generic drugs manufactured in India are linked to significantly more “severe adverse events” for patients who use them than equivalent drugs produced in the United States, a new […]

Blood pressure drug could be a safer alternative for treating ADHD symptoms, finds study

Written by | 28 Feb 2025

Repurposing amlodipine, a commonly used blood pressure medicine, could help manage attention-deficit/ hyperactivity disorder (ADHD) symptoms, according to an international study involving the University of Surrey. In a […]

Faster drug development with the help of artificial intelligence

Written by | 26 Jan 2025

The discovery and development of drugs in pharmacological research – including the risk assessment of active substances in the early phase of drug development – still largely relies […]

Psilocybin shows increasing efficacy for treatment of depression

Written by | 22 Sep 2024

Treatment with psilocybin appears to offer long-term antidepressant effects which are comparable to those of standard antidepressant therapy with the SSRI drug escitalopram. Subjects taking psilocybin also reported […]

New research may make future design of nanotechnology safer with fewer side effects

Written by | 13 Oct 2023

A new study may offer a strategy that mitigates negative side effects associated with intravenous injection of nanoparticles commonly used in medicine. The study was published today in Nature […]

New orally available drug for spinal cord injury found to be safe and tolerable in healthy participants

Written by | 12 Aug 2023

New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London has demonstrated the safety and tolerability of a new drug treatment designed as […]

Specialty drugs accounted for most new product launches in the past decade. Why do we know so little about how clinical studies influence their diffusion?

Written by | 20 Jun 2023

Researchers from McGill University and Ontario Tech University published a new Journal of Marketing article that examines the drivers of specialty drug diffusion. The study, forthcoming in the Journal of Marketing, is titled “Scientific Evidence […]

Metformin lowers risk of long COVID

Written by | 10 Jun 2023

Treatment with the diabetes drug metformin immediately after testing positive for the SARS-CoV-2 virus lowers the risk of developing long COVID by 41%. Researchers reported this finding on […]

Using AI to create better, more potent medicines

Written by | 2 Jun 2023

While it can take years for the pharmaceutical industry to create medicines capable of treating or curing human disease, a new study suggests that using generative artificial intelligence […]

Journal of Pharmaceutical Analysis studies shine the light on advancements in pharmaceutical analytical techniques and overcoming chemoresistance

Written by | 1 Jun 2023

Research into new drug development is ongoing at a very fast pace globally. In keeping with newer remedies entering the market, there is a need for optimizing existing […]

Artificial intelligence in pharmaceutical sciences revolutionizes drug research and development

Written by | 27 May 2023

Scientists have long been challenged by the complex process of drug discovery and development, with investments that often go unrewarded. However, with the advancement of experimental technology and […]

Tadalafil shows potential as a diabetes treatment

Written by | 17 May 2023

In a small feasibility study, subjects with type 2 diabetes achieved significant improvement in long-term blood sugar levels following treatment with high-dose tadalafil, an erectile dysfunction drug.  Tadalafil […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.